About Axon Clinical s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Takeda
4
Apellis Pharmaceuticals, Inc.
3
Amgen
2
Bayer
2
Impax Laboratories, LLC
2
Pfizer
2
Arena Pharmaceuticals
1
AstraZeneca
1
Boehringer Ingelheim
1
IVERIC bio, Inc.
1
Ionis Pharmaceuticals, Inc.
1
Clinical Trials at Axon Clinical s.r.o.
During the past decade, Axon Clinical s.r.o. conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 10 clinical trials were completed, i.e. on
average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
2016-01-04
2019-08-06
Completed
644
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
2015-12-18
2018-08-21
Completed
383
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
2016-04-15
2023-05-06
Active, not recruiting
746
Zimura in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
2016-01-01
2020-04-23
Completed
286
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
2016-07-01
2018-09-28
Terminated
1,722
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
2016-09-28
2019-05-13
Completed
147
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
2017-04-19
2021-07-20
Completed
500
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Axon Clinical s.r.o." #1 sponsor was "Takeda" with 4 trials, followed by "Apellis Pharmaceuticals, Inc." with 3 trials
sponsored, "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Impax Laboratories, LLC"
with 2 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Axon Clinical s.r.o."
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Axon Clinical s.r.o.
According to Clinical.Site data, the most researched conditions in "Axon Clinical s.r.o." are
"Geographic Atrophy" (4 trials), "Ulcerative Colitis" (4 trials), "Colitis, Ulcerative" (3 trials), "Crohn's Disease" (3 trials) and "Macular Degeneration" (3 trials). Many other conditions were trialed in "Axon Clinical s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at Axon Clinical s.r.o.
Most popular intervention types in "Axon Clinical s.r.o." are "Drug" (27 trials), "Other" (6 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Etrasimod" (3 trials), "Sham Procedure" (3 trials), "APL-2" (2 trials) and "Aflibercept" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Axon Clinical s.r.o.
The vast majority of trials in "Axon Clinical s.r.o." are
28 trials for "All" genders.
Clinical Trials Status at Axon Clinical s.r.o.
Currently, there are NaN active trials in "Axon Clinical s.r.o.".
undefined are not yet recruiting,
4 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Axon Clinical s.r.o.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Axon Clinical s.r.o., 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Axon Clinical s.r.o.
Axon Clinical s.r.o. has several departments that took part in Clinical trials: "Kardio Michal Cepelak sro" - 2 trials, "Kardio-Pisova s.r.o." - 2 trials
Departments List
Name
City
Trials